95 related articles for article (PubMed ID: 26356402)
1. [Melatonin in the correction of sleep in post-stroke patients].
Vinogradov OI; Ivanova DS; Davidov NP; Kuznetsov AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):86-89. PubMed ID: 26356402
[TBL] [Abstract][Full Text] [Related]
2. Objective Sleep Measures in Inpatients With Subacute Stroke Associated With Levels and Improvements in Activities of Daily Living.
Huang RJ; Lai CH; Lee SD; Pai FY; Chang SW; Chung AH; Chang YF; Ting H
Arch Phys Med Rehabil; 2018 Apr; 99(4):699-706. PubMed ID: 29339206
[TBL] [Abstract][Full Text] [Related]
3. [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
Litvinenko IV; Krasakov IV; Tikhomirova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):26-30. PubMed ID: 23388588
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
[TBL] [Abstract][Full Text] [Related]
5. [Melatonin in therapy of sleep disorders age-related estrogen deficiency].
Madaeva IM; Danusevich IN; Zhambalova RM; Kolesnikova LI
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):81-84. PubMed ID: 28638037
[TBL] [Abstract][Full Text] [Related]
6. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
Luthringer R; Muzet M; Zisapel N; Staner L
Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study.
Almeida Montes LG; Ontiveros Uribe MP; Cortés Sotres J; Heinze Martin G
J Psychiatry Neurosci; 2003 May; 28(3):191-6. PubMed ID: 12790159
[TBL] [Abstract][Full Text] [Related]
8. [The results of Russian multicenter open-label observational study of the efficacy and safety of мelaxen (melatonin) for the treatment of disordered sleep in patients with chronic cerebral ischemia].
Poluéktov MG; Levin IaI; Boĭko AN; Skoromets AA; Bel'skaia GN; Gustov AV; Doronin BM; Poverennova IE; Spirin NN; Iakupov EZ
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):26-31. PubMed ID: 23235408
[TBL] [Abstract][Full Text] [Related]
9. Objective and subjective sleep problems and quality of life of rehabilitation in patients with mild to moderate stroke.
Kim WH; Yoo YH; Lim JY; Kang SG; Jung HY; Bae JN; Joa KL
Top Stroke Rehabil; 2020 Apr; 27(3):199-207. PubMed ID: 31618116
[No Abstract] [Full Text] [Related]
10. Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.
Jain SV; Horn PS; Simakajornboon N; Beebe DW; Holland K; Byars AW; Glauser TA
Sleep Med; 2015 May; 16(5):637-44. PubMed ID: 25862116
[TBL] [Abstract][Full Text] [Related]
11. Melatonin in children and adolescents with insomnia: a retrospective study.
Ivanenko A; Crabtree VM; Tauman R; Gozal D
Clin Pediatr (Phila); 2003; 42(1):51-8. PubMed ID: 12635982
[TBL] [Abstract][Full Text] [Related]
12. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.
Dawson D; Rogers NL; van den Heuvel CJ; Kennaway DJ; Lushington K
J Biol Rhythms; 1998 Dec; 13(6):532-8. PubMed ID: 9850013
[TBL] [Abstract][Full Text] [Related]
13. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of sleep disorders in patients with mild cranial-brain injury in the early rehabilitation period].
Ivanova DS; Kulikova IS; Vinogradov OI; Kuznetsov AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):75-7. PubMed ID: 24988965
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
16. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
Braam W; Didden R; Smits M; Curfs L
J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
[TBL] [Abstract][Full Text] [Related]
17. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
Hughes RJ; Sack RL; Lewy AJ
Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
[TBL] [Abstract][Full Text] [Related]
18. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
19. Melatonin administration in insomnia.
James SP; Sack DA; Rosenthal NE; Mendelson WB
Neuropsychopharmacology; 1990 Feb; 3(1):19-23. PubMed ID: 2306332
[TBL] [Abstract][Full Text] [Related]
20. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
